2,674 results found

FDA posted warning letters to drug and device manufacturers, as well as one fertility center, for violations related to CGMP.

The so-called "Skittles Ban" is no more, but earlier this week the California legislature passed a novel bill that would ban four food additives from grocery store shelves starting in 2027.

Massachusetts has taken a drastic and abrupt step by banning the sale of all vaping products, nicotine and THC, within its state borders for the next four months.

3M Company tested that proposition and lost in multidistrict litigation involving design defect and failure to warn claims over earplugs issued to members of the United States military.

Members of Wilson Elser's Cannabis Law practice attended a teleconference led by California Insurance Commissioner Dave Jones with 63 insurance industry stakeholders on May 22, 2017...

In an effort to avoid the impact of the completed operations aggregate limit, policyholder counsel sometimes attempt to characterize claims as (1) rip-out exposures, or (2) as relating to "abandoned or unused materials," so as to come within a common insurance policy carve-out from the Completed Operations Hazard.

On this site, we previously reported about the comprehensive rule changes made in New York to a defendant's obligation to provide disclosure regarding available insurance coverage.

On April 15, 2008, the New York Appellate Division, First Department, affirmed a lower court's determination that product liability claims arising from the manufacture and distribution of the same product constitute multiple occurrences under general liability policies.

A fundamental principle of trademark law requires a trademark owner to control the nature and quality of the goods or services sold under a licensed mark.

When most consumer product companies think about the Consumer Product Safety Commission (CPSC), they think recalls and injury prevention.

A major drug or medical device recall often is followed by a spate of product liability lawsuits by claimants hoping for recovery made easier by the manufacturer's perceived admissions in the recall notice.

Last week, we found ourselves focusing on spoliation issues in two different cases, one at the front-end (an early case assessment) and one at the back-end (haggling over jury instructions).

Zurbriggen underscores that plaintiffs alleging injury from consumer products must present reliable expert causation evidence and signals courts’ resistance to the use of equitable doctrines like res ipsa loquitur to substitute for proof of defect, exposure, and causation.

Delaware’s amended Rule 26(b) draws a clear line on litigation funding disclosure: funder existence, identity, and control rights are discoverable, but the agreement’s substance and the funder’s work product are not, absent a showing of cause. The rule lands squarely in the middle of a fast-diverging national landscape on third-party litigation funding disclosure requirements.

On December 11, 2008, the Florida Supreme Court issued a ruling invalidating pre-injury releases signed by parents on behalf of their minor children when children are injured participating in commercial activities.

The first is when a vendor willfully and unlawfully sells or furnishes alcohol to an underage patron who then causes injury or damage to another.

Rapid advances in medical science are bringing an astonishing array of new therapies to patients. At the same time, those advances raise significant questions about how to strike an appropriate balance between patient safety and the availability of potentially lifesaving drugs and medical devices.